Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V

NCT02389946 is registered in ClinicalTrials.gov with Biotronik, Inc. as lead sponsor.

NCT NCT02389946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02389946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V
Lead sponsor
Biotronik, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2015
Completion date
March 31, 2021
Enrollment
1,334 (actual)
Sites
92

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, angina pectoris, atherosclerosis, coronary, coronary artery disease, ischemic heart disease, myocardial ischemia